GC
Grimes & Company Portfolio holdings
AUM
$3.67B
This Quarter Return
-2.27%
1 Year Return
+12.49%
3 Year Return
+42.9%
5 Year Return
+87.85%
10 Year Return
+203.44%
AUM
$3.23B
AUM Growth
+$3.23B
(-6.8%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
42.87%
Holding
405
New
25
Increased
177
Reduced
155
Closed
37
Top Buys
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
$112M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$32.7M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
$18.6M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
$15.3M |
| 5 |
Micron Technology
MU
|
$14.5M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$80.4M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$62.2M |
| 3 |
SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
|
$60.4M |
| 4 |
Vanguard Small-Cap ETF
VB
|
$27.9M |
| 5 |
DocuSign
DOCU
|
$19.8M |
Sector Composition
| 1 | Technology | 14.38% |
| 2 | Healthcare | 6.83% |
| 3 | Financials | 4.82% |
| 4 | Industrials | 3.49% |
| 5 | Communication Services | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dimensional Emerging Core Equity Market ETF
DFAE
$6.41B
| $9.8M | 0.3% | 378,657 +66,599 | +21% | +$1.72M |
|
77
Berkshire Hathaway Class B
BRK.B
$1.09T
| $9.58M | 0.3% | 17,990 +326 | +2% | +$174K |
|
78
Nike
NKE
$114B
| $9.54M | 0.3% | 150,332 +47,487 | +46% | +$3.01M |
|
79
Schwab US Large- Cap ETF
SCHX
$59B
| $9.44M | 0.29% | 427,552 -106,096 | -20% | -$2.34M |
|
80
PayPal
PYPL
$67.1B
| $9.33M | 0.29% | 142,962 +1,589 | +1% | +$104K |
|
81
Vanguard Consumer Discretionary ETF
VCR
$6.41B
| $9.26M | 0.29% | 28,452 -13,039 | -31% | -$4.24M |
|
82
Avantis US Large Cap Equity ETF
AVLC
$693M
| $9.23M | 0.29% | 143,814 +75,802 | +111% | +$4.87M |
|
83
Exxon Mobil
XOM
$487B
| $9.22M | 0.29% | 77,561 -66 | -0.1% | -$7.85K |
|
84
DexCom
DXCM
$29.5B
| $9.21M | 0.28% | +134,935 | New | +$9.21M |
|
85
Clorox
CLX
$14.5B
| $8.73M | 0.27% | +59,264 | New | +$8.73M |
|
86
Biogen
BIIB
$19.4B
| $8.12M | 0.25% | 59,334 +33,721 | +132% | +$4.61M |
|
87
SPDR Portfolio Developed World ex-US ETF
SPDW
$29.1B
| $8M | 0.25% | 219,649 -10,888 | -5% | -$396K |
|
88
Comcast
CMCSA
$125B
| $7.97M | 0.25% | 215,880 +21,668 | +11% | +$800K |
|
89
Thermo Fisher Scientific
TMO
$186B
| $7.96M | 0.25% | 15,999 +1,609 | +11% | +$801K |
|
90
iShares MSCI EAFE ETF
EFA
$66B
| $7.93M | 0.25% | 97,006 -1,653 | -2% | -$135K |
|
91
Abbott
ABT
$231B
| $7.82M | 0.24% | 58,975 +851 | +1% | +$113K |
|
92
McCormick & Company Non-Voting
MKC
$18.9B
| $7.66M | 0.24% | 93,096 +8,559 | +10% | +$704K |
|
93
Novo Nordisk
NVO
$251B
| $7.43M | 0.23% | 106,953 +3,273 | +3% | +$227K |
|
94
Lockheed Martin
LMT
$106B
| $7.36M | 0.23% | 16,481 +503 | +3% | +$225K |
|
95
Lear
LEA
$5.85B
| $6.96M | 0.22% | 78,917 +32,019 | +68% | +$2.82M |
|
96
Mastercard
MA
$538B
| $6.41M | 0.2% | 11,697 -29 | -0.2% | -$15.9K |
|
97
Generac Holdings
GNRC
$10.9B
| $6.27M | 0.19% | +49,468 | New | +$6.27M |
|
98
JPMorgan International Research Enhanced Equity ETF
JIRE
$8.3B
| $6.24M | 0.19% | 97,868 +49,833 | +104% | +$3.18M |
|
99
GSK
GSK
$79.9B
| $6.06M | 0.19% | 156,309 +16,434 | +12% | +$637K |
|
100
Schwab International Equity ETF
SCHF
$50.3B
| $5.88M | 0.18% | 297,339 +619 | +0.2% | +$12.2K |
|